C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773)
11/2006
11/30/2006	WO2006125805A1 Thiazole derivatives and use thereof
11/30/2006	WO2006125803A1 Thiazole derivatives and use thereof
11/30/2006	WO2006125402A1 A process for the crystallization of rosiglitazone and its derivatives from mixed solvents
11/30/2006	WO2006125370A1 Aromatic ether compounds,preparation and usage thereof
11/30/2006	WO2006103045B1 Compounds comprising an oxazole or thiazole moiety, processes for making them, and their uses
11/30/2006	US20060270721 EP4 receptor agonist, compositions and methods thereof
11/30/2006	US20060270706 Cyclic amine derivative having heteroaryl ring
11/30/2006	US20060270704 potassium channel modulators such as 4-(3-fluorophenyl)-6-methoxy-N,N,2-trimethyl-1-oxo-1,2-dihydroisoquinoline-3-carboxamide, used as antiarrhythmia agents; cardiovascular disorders
11/30/2006	US20060270685 Anhydrous ziprasidone mesylate and a process for its preparation
11/30/2006	US20060270684 Crystalline forms of ziprasidone mesylate
11/30/2006	US20060270673 Inhibitors of akt activity
11/30/2006	US20060270670 Methods of synthesizing 6-alkylaminoquinoline derivatives
11/30/2006	US20060270666 Quinoxaline derivatives as neutrophil elastase inhibitors and their use
11/30/2006	US20060270657 N-substituted heterocyclic sulfonamides
11/30/2006	US20060270656 Substituted piperazines of azepines, oxazepines and thiazepines
11/30/2006	US20060270652 Benzimidazole-carboxamide compounds as 5-HT4, receptor agonists
11/30/2006	US20060270649 Azetidine derivatives, their preparation and medicaments containing them
11/30/2006	CA2609394A1 Pyrazole compound and therapeutic agent for diabetes comprising the same
11/30/2006	CA2609235A1 Heteroaryl benzamide derivatives for use as glk activators in the treatment of diabetes
11/30/2006	CA2608687A1 New antibiotic derivatives
11/30/2006	CA2608153A1 Thiazole derivatives for use as p13k modulators
11/30/2006	CA2608143A1 Thiazole derivatives and use thereof
11/30/2006	CA2607385A1 Thiazole derivatives and their use for the treatment and/or prophylaxis of disorders and diseases
11/29/2006	EP1726952A1 Method of in vivo screening of therapeutic agent for memory/learning dysfunction by schizophrenia
11/29/2006	EP1726586A1 Dihydronaphthalene derivative compounds and agent comprising the derivative as active ingredient
11/29/2006	EP1726585A1 Diaryl-substituted five-membered heterocycle derivative
11/29/2006	EP1726580A1 Aminophenylpropanoic acid derivative
11/29/2006	EP1725632A1 New materials for injecting or transporting holes and organic electroluminescence devices using the same
11/29/2006	EP1725551A1 Oxidized thioether derivatives of styryl-azoles and their use as her tyrosine kinases inhibitors
11/29/2006	EP1725545A1 Composition comprising an optically-active monomeric compound, method implementing said composition, monomeric compound, polymer comprising same, and use thereof
11/29/2006	EP1725544A1 3-[4-heterocyclyl-1,2,3-triazol-1-yl]-n-aryl-benzamides as inhibitors of the cytokines production for the treatment of chronic inflammatory diseases
11/29/2006	EP1725543A1 4-benzimidazol-2-yl-pyridazine-3-one-derivatives, production and use thereof in medicaments
11/29/2006	EP1725540A1 Diaminopyrimidines as p2x3 and p2x2/3 antagonists
11/29/2006	EP1725535A2 Hiv integrase inhibitors
11/29/2006	EP1725529A1 Bis bicyclic amides as vanilloid receptor ligands and their use in treatments of inflammatory and neuropatic pain
11/29/2006	EP1725232A1 (indol-3-yl)-heterocycle derivatives as agonists of the cannabinoid cb1 receptor
11/29/2006	EP1725103A1 Substituted 4-(4-trifluoromethylpyrazolyl)-pyrimidines serving as herbicides
11/29/2006	EP1725102A1 Hiv integrase inhibitors
11/29/2006	EP1651642A4 Pna monomer and precursor
11/29/2006	EP1572207A4 N-(substituted arylmethyl)-4-(disubstituted methyl) piperidines and pyridines
11/29/2006	EP1553947A4 Quinazolinones and derivatives thereof as factor xa inhibitors
11/29/2006	CN1871234A 2-amino-4-heteroarylethyl thiazoline derivatives and their use as inhibitors of inducible no-synthase
11/29/2006	CN1871225A Preferentially substituted calcium channel blockers
11/29/2006	CN1871224A 2-arylimino-2,3-dihydrothiazole derivatives, methods for preparing them and therapeutic use thereof
11/29/2006	CN1871216A Inhibitors of cathepsin s
11/29/2006	CN1871012A 7 and 8 membered heterocyclic cyclopentyl benzylamide modulators of chemokine receptor activity
11/29/2006	CN1870997A Treatment agent for keratoconjunctival disorder
11/29/2006	CN1286835C Phenylacetamido-thiazole derivatives, process for their preparation and their use as antitumor agents
11/29/2006	CN1286834C Benzothiazoles compound
11/29/2006	CN1286833C Indole and 2,3-indoline derivative, their preparation and application
11/29/2006	CN1286815C Novel 4-anilinoquinoline-3-carboxamides compound
11/29/2006	CN1286812C Bispiperidines as antithrombotic agents
11/28/2006	US7141672 Oxazole-aryl-carboxylic acids useful in the treatment of insulin resistance and hyperglycemia
11/28/2006	US7141609 α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
11/28/2006	US7141596 Inhibitors of proteins that bind phosphorylated molecules
11/28/2006	US7141595 Amino benzothiazole compounds with NOS inhibitory activity
11/28/2006	US7141594 inhibitors of HIV protease for treating AIDS
11/28/2006	US7141588 N-aryl-2-oxazolidinone-5-carboxamides and their derivatives
11/28/2006	US7141584 2-(substituted-phenyl)amino-imidazoline derivatives
11/28/2006	US7141583 Activity against both Gram-positive and Gram-negative pathogens are generally regarded as having a broad spectrum of activity
11/28/2006	US7141580 activity as prostaglandin E2 receptor antagonists
11/28/2006	US7141574 Viral polymerase inhibitors
11/28/2006	US7141564 are active against a wide range of organisms including both Gram-negative and Gram-positive organisms
11/28/2006	US7141561 Substituted diaryl heterocycles, process for their preparation and their use as medicaments
11/28/2006	US7141533 optionally substituted thiazolyl, oxazolyl or pyrazolyl substituted heterocycles; use as pesticides and herbicides
11/28/2006	CA2378007C Benzimidazole compounds
11/28/2006	CA2228044C Dibenzimidazole radioprotectors
11/28/2006	CA2164633C Benzoylbenzofurane derivatives for treatment of cardiac arrhythmia
11/28/2006	CA2113603C Tricyclic condensed heterocyclic compounds, their production and use
11/23/2006	WO2006125130A1 Methods for synthesizing heterocyclic compounds
11/23/2006	WO2006124887A1 Iminothiazolidinone derivatives as sfrp-1 antagonists
11/23/2006	WO2006124816A1 Fluorescent chemical compounds having high selectivity for double stranded dna, and methods for their use
11/23/2006	WO2006124744A1 Bicyclic derivatives as modulators of ion channels
11/23/2006	WO2006124447A2 Substituted n-arylpyrrolidines as selective androgen receptor modulators
11/23/2006	WO2006123725A1 Pyrrolidine derivative or salt thereof
11/23/2006	WO2006123639A1 Pyrimidine derivative
11/23/2006	WO2006123249A2 Novel oxadiazole derivatives and their use as positive allosteric modulators of metabotropic glutamate receptors
11/23/2006	WO2006123121A1 Histone deacetylase inhibitors
11/23/2006	WO2006123088A2 4- (thiazol-2-ylthioalkyl) -pyrazoles and their use as herbicides
11/23/2006	WO2006122661A1 Heteroaryl-carboxylic acid (sulfamoyl alkyl) amide - derivatives as factor xa inhibitors
11/23/2006	WO2006110884A3 2, 6-di (hetero) aryl -4-amido-pyrimidines as adenosine receptor antagonists
11/23/2006	WO2006106437A3 Substituted oxazole derivatives and their use as tyrosine kinase inhibitors
11/23/2006	WO2006096652A3 Process for preparing macrocyclic compounds
11/23/2006	WO2006069155A3 Inhibitors of protein arginine methyl transferases
11/23/2006	US20060264639 crystalline rosiglitazone maleate filtration
11/23/2006	US20060264631 Benzooxazole and benzothiazole antagonists of gonadotropin releasing hormone receptor
11/23/2006	US20060264627 Heterocyclic hydrazones as novel anti-cancer agents
11/23/2006	US20060264618 Protease inhibitor conjugates and antibodies useful in immunoassay
11/23/2006	US20060264486 (5-{3-[4-(4,5,6,7-tetrahydro-benzooxazol-2-yl)-phenoxy]-propoxy}-indol-1-yl)-acetic acid; diabetes, obesity, hyperlipidemia, and atherosclerotic disease
11/23/2006	US20060264483 Sulfonylalkanoylamino hydroxyethylamino sulfonamide retroviral protease inhibitors
11/23/2006	US20060264482 Epothilones C, D, E and F, preparation and compositions
11/23/2006	US20060264479 Nicotinamide Derivatives Useful as p38 Inhibitors
11/23/2006	US20060264464 Amidino compounds as cysteine protease inhibitors
11/23/2006	US20060264462 Imidazolamino compounds
11/23/2006	US20060264461 Imidazolamino compounds
11/23/2006	US20060264435 Novel compounds
11/23/2006	US20060264434 Chemokine receptor binding heterocyclic compounds
11/23/2006	US20060264432 Adenosine A1, A2a, and A2b receptor ligands; coupling the 2-mercapto-3,5-dicyano-4-aryl-6-aminopyridine to a substituted alkyl or alkenyl compound; antiischemic agents; cardiovascular disorders
11/23/2006	US20060264430 Pyrazole derivative
11/23/2006	US20060264429 Benzoxazinone derivatives, preparation thereof and uses in the treatment of cns and other disorders

1 ... 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 272 273 ... 628